Trump¿s covid-19 treatment: Is there any better approach? - Al'-Mosawi, Aamir
30,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
15 °P sammeln
  • Broschiertes Buch

On the first of October 2020, Donald Trump tested positive for SARS-CoV-2. Most media including the CNN television channel rightly confirmed that Mr. Trump has been treated by the best doctors in the world with best therapies that could possibly help him in defeating the virus. The CNN, in various programs during the first week of October, emphasized that, American citizens with Covid-19 are not receiving the same treatments as their president. The use of a therapeutic approach including experimental antibody therapy, remdesivir and dexamethasone has not been reported as a treatment for one…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
On the first of October 2020, Donald Trump tested positive for SARS-CoV-2. Most media including the CNN television channel rightly confirmed that Mr. Trump has been treated by the best doctors in the world with best therapies that could possibly help him in defeating the virus. The CNN, in various programs during the first week of October, emphasized that, American citizens with Covid-19 are not receiving the same treatments as their president. The use of a therapeutic approach including experimental antibody therapy, remdesivir and dexamethasone has not been reported as a treatment for one patient before other than Trump. In the paper we would like first to emphasize that the best doctors in the world are those who can offer the best therapies for all patients or the majority of patients, and not those who can offer treatment for one patient like Trump. Obviously, of the three important therapies, only dexamethasone can be offered to almost all the patients with covid-19. The aim of this paper is to assume that all the patients in the world are as important as Trump and tries to offer them the best evidence-based treatment.
Autorenporträt
Aamir Jalal Al-Mosawi è medico consulente presso il Centro nazionale di formazione e sviluppo del Ministero della Salute iracheno e la Città medica di Baghdad. È stato capo della sede irachena del gruppo internazionale di scienziati Copernicus (2006-ottobre 2020). È anche membro del consiglio consultivo dell'Associazione internazionale dei collegi medici (IAMC), dal 2008.